Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice?

Clinical Rheumatology

Volumn 30, Issue 12, 2011, Pages 1577-1582

  Madsen, Ole Rintek ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Agreement; Biological treatment; C reactive protein; DAS28; Interchangeability; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGISTRIES; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; STATISTICS AS TOPIC;

EID: 82655173822     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1847-6     Document Type: Article

References (32)

1. DMFM Van der Heijde MA van't Hof PLCM van Riel LAM Theunisse EW Lubberts MA van Leeuwen, et al. 1990 Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score Ann Rheum Dis 49 916 920 2256738 10.1136/ard.49.11.916 (Pubitemid 20360757)
2. DMFM Van der Heijde MA van't Hof PLCM van Riel MA van Leeuwen MH van Rijswijk LBA van de Putte 1992 Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis Ann Rheum Dis 51 177 181 1550400 10.1136/ard.51.2.177
3. ML Prevoo MA van 't Hof HH Kuper MA van Leeuwen LB van de Putte PL van Riel 1995 Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44 48 7818570 10.1002/art.1780380107 1:STN:280:DyaK2M7hvVeqtA%3D%3D
4. AM van Gestel CJ Haagsma PL van Riel 1998 Validation of rheumatoid arthritis improvement criteria that include simplified joint counts Arthritis Rheum 41 1845 1850 9778226 10.1002/1529-0131(199810)41:10<1845::AID- ART17>3.0.CO;2-K (Pubitemid 28465539)
5. J Fransen PMJ Welksing RMH de Keijzer PLCM van Riel 2003 Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity Ann Rheum Dis 62 151 10.1136/ard.62.7.624 (Pubitemid 36760558)
6. S Ringold NG Singer 2008 Measures of disease activity in rheumatoid arthritis: a clinician's guide Curr Rheumatol Rev 4 259 265 10.2174/ 157339708786263951
7. J Fransen PL van Riel 2009 The disease activity score and the EULAR response criteria Rheum Dis Clin North Am 35 745 757 19962619 10.1016/j.rdc.2009.10.001
8. http://www.das-score.nl/www.das-score.nl/. Accessed 25 February 2011
9. AM van Gestel ML Prevoo MA van 't Hof MH van Rijswijk LB van de Putte PL van Riel 1996 Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria Arthritis Rheum 39 34 40 8546736 10.1002/art.1780390105 (Pubitemid 26036375)
10. AM van Gestel JJ Anderson PL van Riel M Boers CJ Haagsma B Rich, et al. 1999 ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology J Rheumatol 26 705 711 10090187 (Pubitemid 29125596)
11. YP Goekoop-Ruiterman JK de Vries-Bouwstra PJ Kerstens MM Nielen K Vos D van Schaardenburg 2010 DAS-driven therapi versus routine care in patients with recent-onset rheumatoid arthritis Ann Rheum Dis 69 65 69 19155234 10.1136/ard.2008.097683 1:STN:280:DC%2BD1MfhsFWitg%3D%3D
12. B Kuriya EV Arkema VP Bykerk EC Keystone 2010 Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission Ann Rheum Dis 69 1298 1304 20421343 10.1136/ard.2009.118307 1:CAS:528:DC%2BC3cXhtVSltbfJ
13. T Sokka S Toloza M Cutolo H Kautiainen H Makinen F Gogus, et al. 2009 Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study Arthritis Res Ther 11 R7 19144159
14. PL van Riel J Fransen 2005 DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis Arthritis Res Ther 7 189 190 16207346 10.1186/ar1820 (Pubitemid 41335153)
15. DM van der Heijde JW Jacobs 1998 The original "DAS" and the "DAS28" are not interchangeable: comment on the articles by Prevoo et al Arthritis Rheum 41 942 945 9588750 10.1002/1529-0131(199805)41:5<942::AID- ART26>3.0.CO;2-B
16. ML Hetland IJ Christensen U Tarp L Dreyer A Hansen IT Hansen, et al. 2010 Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab Arthritis Rheum 62 22 32 20039405 10.1002/art.27227 1:CAS:528:DC%2BC3cXhtFGnurnP
17. JM Bland DG Altman 1986 Statistical methods for assessing agreement between two methods of clinical measurement Lancet 327 307 310 10.1016/S0140-6736(86)90837-8 (Pubitemid 16134762)
18. JM Bland DG Altman 1996 Statistics notes: measurement error BMJ 313 744 8819450 10.1136/bmj.313.7059.744 1:STN:280:DyaK28vhs1Kmtw%3D%3D
19. G Wells JC Becker J Teng M Dougados M Schiff J Smolen, et al. 2009 Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate Ann Rheum Dis 68 954 960 18490431 10.1136/ard.2007.084459 1:CAS:528:DC%2BD1MXotVCjtbk%3D
20. I Kushner 1991 C-reactive protein in rheumatology Arthritis Rheum 34 1065 1068 1859483 10.1002/art.1780340819 1:STN:280:DyaK3MzhsFKhsA%3D%3D
21. I Talstad P Scheie H Dalen J Roli 1983 Influence of plasma proteins on erythrocyte morphology and sedimentation Scand J Haematol 31 478 484 6648360 10.1111/j.1600-0609.1983.tb01547.x 1:CAS:528:DyaL2cXkvFahuw%3D%3D (Pubitemid 14232174)
22. MA van Leeuwen MH van Rijswijk DM van der Heijde GJ Te Meerman PL van Riel PM Houtman, et al. 1993 The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease Br J Rheumatol 32 9 13 8508266 (Pubitemid 23193420)
23. RK Mallya FC de Beer H Berry ED Hamilton BE Mace MB Pepys 1982 Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate J Rheumatol 9 224 228 7097681 1:STN:280:DyaL383ktF2jsw%3D%3D (Pubitemid 12014862)
24. F Wolfe 1997 Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis J Rheumatol 24 1477 1485 9263138 1:CAS:528:DyaK2sXls1Sgurc%3D (Pubitemid 27320685)
25. EM Hensor P Emery SJ Bingham PG Conaghan YEAR Consortium 2010 Discrepancies in categorizing rheumatoid arthritis patients by DAS-28(ESR) and DAS-28(CRP): can they be reduced? Rheumatology 49 1521 1529 20435650 10.1093/rheumatology/keq117
26. T Matsui Y Kuga J Kaneko Y Eto N Chiba M Yasuda, et al. 2007 Disease activity score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan Ann Rheum Dis 66 1221 1226 17369281 10.1136/ard.2006.063834 1:CAS:528:DC%2BD2sXhtVKltL7E (Pubitemid 47309741)
27. E Inoue H Yamanaka M Hara T Tomatsu N Kamatani 2007 Comparison of disease activity score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein thresholds values Ann Rheum Dis 66 407 409 16926186 10.1136/ard.2006. 054205 1:CAS:528:DC%2BD2sXjvFSht7o%3D (Pubitemid 46579645)
28. I Castrejõn AM Ortiz R Garcia-Vicuña JP Lopez-Bote A Humbría L Carmona, et al. 2008 Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol 26 769 775 19032807
29. van Riel PL ed. (2004) Disease activity. EULAR handbook of clinical assessment in rheumatoid arthritis. Van Zuiden Communications BV, the Netherlands, p 37
30. A Van der Maas CHM van den Ende J van Eerd J Fransen AA den Broeder 2010 The use of different methods for rapid determination of the ESR induces DAS28 misclassification in clinical practice Clin Exp Rheumatol 28 477 482 20598225
31. F Wolfe JT Sharp 1998 Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression Arthritis Rheum 41 1571 1582 9751089 10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R 1:STN:280:DyaK1cvitFOjuw%3D%3D (Pubitemid 28459915)
32. H Mäkinen H Kautiainen P Hannonen T Möttönen M Korpela M Leirisalo-Repo, et al. 2007 Disease activity score 28 as an instrument to measure disease activity in patients with early rheumatoid arthritis J Rheumatol 34 1987 1991 17611990 (Pubitemid 47548199)